We observed no difference in T4 perforin expression during the acute phase of infection between patients who developed long COVID 13 months later or not (7.2 ± 8.3% versus 6.9 ± 3.8%, p = 0.919, Figure 5A). The gene discussed is PRF1; the disease is infection.